AstraZeneca has just scored big on the quest to make routine vaccinations less of a hassle.
The FDA has signed off on the British drugmaker’s influenza vaccine FluMist for self-administration by adults up to 49 years old and for administration by a parent or caregiver in kids between the ages of 2 and 17.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2025,